For complete information on Nivalin: https://www.nivalin.com
Nivalin.com addresses various clinical topics on Nivalin (Galantamine): Galantamine and the adrenal glands, safety and toxicity, mutagenicity of Galantamine, clinical application.
Excessive Decurarizing Drug
Nivalin is an original phytopreparation developed by Sopharma's own research team and produced with an original technology for extraction of the alkaloid Galantamine from the bulbs of the plant snowdrops (Leucojum aestivum). Galantamine is the active ingredient in Nivalin.
Nivalin, Galantamine mechanism of action
Nivalin is competitive reversible inhibitor of Acetylcholinesterase (AChE) and prolongs the hydrolysis of endogenous mediator acetylcholine, thereby increasing its accumulation in the choline sensitive postsynaptic membranes.
Sopharma offers Nivalin as:
Ampoules of 1 ml in the concentrations of 1 mg; 2.5 mg; 5 mg and 10 mg. Tablets in concentrations of 5 mg in package of 60 count and 10 mg in package of 20 count.
Nivalin Anticholinesterase activity
Nivalin inhibits reversibly brain, erythrocytic, muscle and serum cholinesterase. Its effect on brain cholinesterase is 10-12 times as potent, compared to physostigmine, since Nivalin crosses the blood-brain barrier.
Copyright © 2016-2017 BPG Ltd/Biogenic Stimulants, Inc. All rights reserved.